Inspire Medical Systems logo
Inspire Medical Systems INSP
$ 130.89 -4.72%

Quarterly report 2025-Q3
added 11-03-2025

report update icon

Inspire Medical Systems EPS Ratio 2011-2025 | INSP

EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.

The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.

Calculated as:

EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]

EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.

A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.

EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.

Annual EPS Ratio Inspire Medical Systems

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.8 -0.72 -1.6 -1.54 -2.19 -1.4 -1.5 -14.9 -16.9 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.8 -16.9 -4.33

Quarterly EPS Ratio Inspire Medical Systems

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
0.34 -0.12 0.1 - 0.62 0.33 -0.34 - -0.29 -0.41 -0.53 - -0.6 -0.53 -0.61 - -0.38 -0.48 -0.6 -0.28 -0.39 -0.88 -0.67 -0.38 -0.34 -0.32 -0.35 -0.22 -0.22 -0.43 -5.05 -3.46 -3.42 -4.14 -3.9 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
0.62 -5.05 -0.902

References

  1. Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.

EPS Ratio of other stocks in the Medical devices industry

Issuer EPS Ratio Price % 24h Market Cap Country
Abiomed Abiomed
ABMD
5 - - $ 17.2 B usaUSA
Acutus Medical Acutus Medical
AFIB
-2.81 - -26.83 % $ 2.62 M usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
-0.54 $ 3.86 -3.26 % $ 134 M usaUSA
Bio-Rad Laboratories Bio-Rad Laboratories
BIO
-25.6 $ 307.92 -1.93 % $ 8.69 B usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
-0.98 - - $ 475 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
-0.75 - 37.08 % $ 85.7 M usaUSA
Bruker Corporation Bruker Corporation
BRKR
0.76 $ 45.13 -2.67 % $ 6.72 K usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
-0.48 - 3.58 % $ 2.21 M usaUSA
Abbott Laboratories Abbott Laboratories
ABT
7.67 $ 125.1 1.48 % $ 218 B usaUSA
Boston Scientific Corporation Boston Scientific Corporation
BSX
1.26 $ 92.34 0.64 % $ 136 B usaUSA
Conformis Conformis
CFMS
-6.99 - - $ 16.4 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
-0.51 $ 2.56 8.94 % $ 95.5 M franceFrance
Cardiovascular Systems Cardiovascular Systems
CSII
-0.94 - 0.15 % $ 844 M usaUSA
Cutera Cutera
CUTR
-2.87 - -10.19 % $ 1.99 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
-1.64 $ 17.7 -3.46 % $ 408 M usaUSA
Eargo Eargo
EAR
-39.7 - - $ 10.2 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
-1.43 - 14.99 % $ 929 K usaUSA
Xtant Medical Holdings Xtant Medical Holdings
XTNT
-0.12 $ 0.73 4.33 % $ 97.6 M usaUSA
InMode Ltd. InMode Ltd.
INMD
2.29 $ 14.56 0.76 % $ 1.15 B israelIsrael
Cognyte Software Ltd. Cognyte Software Ltd.
CGNT
-0.17 $ 9.88 0.05 % $ 709 M israelIsrael
Second Sight Medical Products Second Sight Medical Products
EYES
-0.43 - -0.97 % $ 54.4 M usaUSA
Align Technology Align Technology
ALGN
5.63 $ 165.15 0.78 % $ 12.4 B usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
-0.02 $ 1.07 -3.18 % $ 110 M usaUSA
Avinger Avinger
AVGR
-23.3 - -20.74 % $ 369 K usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
-0.7 $ 12.81 -1.23 % $ 346 M usaUSA
FONAR Corporation FONAR Corporation
FONR
1.78 $ 14.86 -0.03 % $ 97.4 M usaUSA
AxoGen AxoGen
AXGN
-0.23 $ 30.33 1.15 % $ 1.34 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
-1.28 - - $ 3.31 B usaUSA
GBS GBS
GBS
-2 - -0.57 % $ 7.12 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
4.29 $ 40.78 2.33 % $ 1.26 B usaUSA
Globus Medical Globus Medical
GMED
0.76 $ 86.83 -2.31 % $ 11.8 B usaUSA
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
-0.09 $ 13.41 -4.56 % $ 1.03 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
-2.07 - 1.37 % $ 20.5 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
-1.13 $ 20.04 0.65 % $ 2.86 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
-8.58 $ 3.4 - $ 5.31 M usaUSA
Establishment Labs Holdings Establishment Labs Holdings
ESTA
-3 $ 72.58 -0.19 % $ 2.04 B costa-ricaCosta-rica
IRIDEX Corporation IRIDEX Corporation
IRIX
-0.59 $ 0.92 -4.72 % $ 14.8 M usaUSA
Electromed Electromed
ELMD
0.89 $ 29.74 0.64 % $ 251 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
1.52 $ 96.35 -1.06 % $ 1.22 B usaUSA